Seebri Neohaler is a prescription drug approved by the Food and Drug Administration (FDA) for long-term maintenance of airway obstruction in people with chronic obstructive pulmonary disease (COPD). Seebri Neohaler is also known by its drug name, Glycopyrrolate.
Seebri Neohaler is an anticholinergic and a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Seebri Neohaler is believed to work by relaxing smooth muscles in the airways. Seebri Neohaler is considered a long-acting bronchodilator.
How do I take it?
Seebri Neohaler is inhaled orally twice a day.
Seebri Neohaler comes in the form of powder... read more